What You Should Know
Lucent Diagnostics (a brand of Quanterix) and Tempus AI have announced a strategic collaboration to integrate Alzheimer’s blood-based biomarker testing into routine clinical workflows.The LucentAD® Complete multi-biomarker blood test will be available for neurologists to order directly through the Tempus clinical ordering platform.The partnership leverages Tempus Next, an AI-enabled care pathway intelligence platform, to identify "care gaps" and identify patients who may
Read More
Archives for 2026
Withings Report Reveals Why Menopause is a Critical Cardiovascular Window
What You Should Know
New Withings report, The Menopause Transition 2026 analyzes real-world data from 2.5 million women across 11 countries to identify physiological shifts during the transition.Atrial Fibrillation (AFib) prevalence increases fourfold globally and 3.8x in the US between early reproductive years and late postmenopause.Heart Rate Variability (HRV), a marker of autonomic resilience, declines by 33% worldwide but only 17% in the US across the menopause stages.Arterial stiffness
Read More
Healthcare Cybersecurity Has Become an Operational Risk, Not Just a Security Function
Healthcare cybersecurity is no longer just a technical discipline handled by IT teams. That view has changed. Cybersecurity in healthcare has grown. It now sits at the intersection of operations, compliance, and patient safety. When systems fail, care is disrupted. These disruptions go beyond data loss, reaching clinical outcomes, financial stability, and regulatory exposure.
This is not a future concern. It is already happening.
Cyber Risk Is Now Operational Risk
Healthcare
Read More
MedTech Breakthrough Announces 2026 Award Winners: Celebrating a Decade of Health Technology Innovation
What You Should Know
MedTech Breakthrough has announced the winners of its 10th annual awards program, recognizing excellence in digital health and medical technology across more than 20 countries.The 2026 awards highlight a decade of evolution where artificial intelligence (AI), virtual care, and precision medicine have become central pillars of global healthcare delivery.This year's program received a record-breaking number of nominations from startups, health systems, and leading global
Read More
Mid-Cycle Revenue Integrity: Leveraging Clinician-Governed AI to Reduce Denials and Understated Acuity
Health systems can deliver appropriate, high-quality care and still see financial and quality outcomes that do not reflect that care. Downgrades, understated acuity, and misaligned quality metrics often arise not because clinical decisions were wrong, but because the full complexity of those decisions and the resulting care were never clearly translated beyond the bedside. In today’s reimbursement environment, outcomes are shaped as much by how care is represented in documentation and coding as
Read More
Wisdom Ventures Closes $77.7M Fund II to Invest in AI-Native Wellbeing Startups
What You Should Know
Wisdom Ventures has closed its $77.7M Fund II, a significant increase from its $10 million Fund I.The fund is backed by prominent technology leaders, including Reid Hoffman (LinkedIn), Evan Sharp (Pinterest), and Stewart Butterfield (Slack).Former U.S. Surgeon General Dr. Vivek Murthy has joined as a Senior Venture Partner to advise on health and wellness investments.Fund I established a strong track record, reaching the top quartile of early-stage funds and including
Read More
Eko Health Appoints Dr. Steven Steinhubl as CMO to Drive Cardiac AI and Global Clinical Strategy
What You Should Know
Eko Health has appointed Steven R. Steinhubl, MD, a prominent cardiologist and digital medicine pioneer, as its Chief Medical Officer (CMO) and executive leadership team member.Dr. Steinhubl will oversee Eko's clinical strategy, research initiatives, and scientific collaborations to accelerate the global adoption of AI-enabled cardiac detection.He currently serves as the Vincent P. Reilly Professor of Biomedical Engineering at Purdue University and is a member of the
Read More
Artera Launches AI Services Model and Agentic AI Squads for Specialty Care and FQHCs
What You Should Know
Artera is the first agentic healthcare company to adopt an AI Services Model, moving away from traditional "homogeneous SaaS" to deliver bespoke, clinic-specific solutions.The company has deployed specialized AI Service Squads—small teams of AI builders who work directly with healthcare providers to co-innovate and eliminate legacy development cycles.The model supports high-demand solutions, including scheduling, prior authorizations, referral management, and closing care
Read More
Elation Health Integrates New AHA and ACC PREVENT™ Cardiovascular Risk Standard
What You Should Know
Elation Health has licensed the American Heart Association (AHA) PREVENT™ risk equations, integrating them directly into its Clinical Insights AI tool.The PREVENT-ASCVD tool became the new clinical standard on March 13, 2026, replacing older models that often overestimated cardiovascular risk by 40–50%.The updated model now includes chronic kidney disease (CKD) as a risk factor for the first time.Leveraging Anthropic’s Claude for Healthcare, Elation achieved a rapid
Read More
Kanvas Biosciences Raises $48M to Advance Spatial Biology Platform and Immuno-Oncology Trials
What You Should Know
Kanvas Biosciences has raised $48M in Series A funding co-led by DCVC and Lions Capital LLC, bringing total funding to $78M.The capital will fund clinical trials for KAN-001, an immuno-oncology drug candidate designed for cancer patients who do not respond to immune checkpoint inhibitors (ICIs).The company utilizes a unique spatial mapping platform to visualize microbial and host cell interactions, overcoming traditional roadblocks in microbiome therapeutic
Read More
